Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 5/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.46 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7268370 | 1.00 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL31744336 | 1.00 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL29767197 | 1.00 | KCNA5 (0.52) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL30887852 | 0.98 | KCNA5 (0.50) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL2230732 | 0.86 | KCNA5 (0.51) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL30596267 | 0.86 | KCNA5 (0.51) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL30910020 | 0.84 | SLC6A2 (0.48) | KCNA5KCNH2CYP1A2ALDH1A1TSHR | |
| SCHEMBL7275282 | 0.84 | KCNA5 (0.50) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL1526122 | 0.84 | KCNA5 (0.50) | KCNA5KCNH2CYP1A2ALDH1A1LMNA | |
| SCHEMBL7293012 | 0.83 | KCNA5 (0.49) | KCNA5KCNH2CYP1A2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4143179-B1 | AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-10-22 | — | — | EP | claimed |
| CN-118126062-A | Dibenzo-1, 3-oxazacyclo-isoquinolin-1 (2H) -one compound, preparation method and application of dibenzo-1, 3-oxazacyclo-isoquinolin-1 (2H) -one compound in resisting plant fungi | 陕西师范大学 | 2024-06-04 | — | — | CN | claimed |
| CN-116505072-A | Lithium ion battery electrolyte and preparation method and application thereof | 惠州锂威新能源科技有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-112830933-A | Synthetic method of 3, 4-dihydro-2H-pyrano [2,3-b ] pyridine | 康化（上海）新药研发有限公司 | 2021-05-25 | — | — | CN | claimed |
| CN-112724757-A | Ionomer coating for eliminating surface charge, preparation method thereof and corresponding coating | 徐宁 | 2021-04-30 | — | — | CN | claimed |
| EP-0990670-B1 | Calcium-based catalyst system | GOODYEAR TIRE & RUBBER (US) | 2004-11-03 | — | — | EP | claimed |
| US-4130510-A | Curing of epoxy resin systems using halfester compounds containing aliphatic tertiary amino groups | HITACHI CHEMICAL CO., LTD. (JP) | 1978-12-19 | — | — | US | claimed |
| US-12545684-B2 | CDK2 inhibitors | BLUEPRINT MEDICINES CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| CN-118126062-B | Dibenzo-1, 3-oxazacyclo-isoquinolin-1 (2H) -one compound, preparation method and application of dibenzo-1, 3-oxazacyclo-isoquinolin-1 (2H) -one compound in resisting plant fungi | 陕西师范大学 | 2026-01-27 | — | — | CN | disclosed |
| EP-4301468-B1 | FGFR3 INHIBITOR COMPOUNDS | LILLY CO ELI (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250122196-A1 | FGFR3 INHIBITOR COMPOUNDS | ELI LILLY AND COMPANY | 2025-04-17 | — | — | US | disclosed |
| US-12209086-B2 | FGFR3 inhibitor compounds | ELI LILLY AND COMPANY (US) | 2025-01-28 | — | — | US | disclosed |
| US-20240383902-A1 | CDK2 INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2024-11-21 | — | — | US | disclosed |
| US-4457934-A | ESTER DERIVATIVE OF PYRIDINE | STAUFFER CHEMICAL COMPANY (US) | 1984-07-03 | — | — | US | disclosed |
| EP-0021663-B1 | A POLYHETEROCYCLIC COMPOUND, ITS PREPARATION AND A SMOKING COMPOSITION IN WHICH IT IS USED | PHILIP MORRIS INCORPORATED (US) | 1983-11-16 | — | — | EP | disclosed |
| US-4407807-A | MOSQUITOES AND HOUSE OR STABLE FLIES | STAUFFER CHEMICAL COMPANY (US) | 1983-10-04 | — | — | US | disclosed |
| US-4348400-A | Pyridylpropyl alkyl-substituted benzoates and their use as insect repellents | STAUFFER CHEMICAL COMPANY (US) | 1982-09-07 | — | — | US | disclosed |
| US-4318418-A | PYRAZINYL COMPOUNDS AS FLAVORANTS | PHILIP MORRIS, INCORPORATED (US) | 1982-03-09 | — | — | US | disclosed |
| EP-0021663-A1 | A polyheterocyclic compound, its preparation and a smoking composition in which it is used | PHILIP MORRIS INCORPORATED (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4130510-A | Curing of epoxy resin systems using halfester compounds containing aliphatic tertiary amino groups | HITACHI CHEMICAL CO., LTD. (JP) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209086-B2 | FGFR3 inhibitor compounds | FGFR3, FGFR1, FGFR2 | KCNA5 4558/4885KCNH2 4552/4885CYP1A2 3488/4885 |
| US-20240383902-A1 | CDK2 INHIBITORS | CDK2, CDK20, CDK2AP1 | KCNA5 4546/4885KCNH2 4773/4885CYP1A2 4273/4885 |
| US-20250122196-A1 | FGFR3 INHIBITOR COMPOUNDS | FGFR3, FGFR1, FGFR2 | KCNA5 4558/4885KCNH2 4552/4885CYP1A2 3488/4885 |
| US-12545684-B2 | CDK2 inhibitors | CDK2, CDK4, CDK1 | KCNA5 4284/4885KCNH2 4232/4885CYP1A2 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.